TADALAFIL TARBIS 20 mg FILM-COATED TABLETS

Introduction

Leaflet: Information for the user

Tadalafil Tarbis 20 mg film-coated tablets EFG

Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any doubts, consult your doctor or pharmacist.
• This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
• If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet

1. What is Tadalafil Tarbis and what is it used for
2. What you need to know before taking Tadalafil Tarbis
3. How to take Tadalafil Tarbis
4. Possible side effects
5. Storage of Tadalafil Tarbis
6. Package contents and additional information

1. What is Tadalafil Tarbis and what is it used for

Tadalafil Tarbis 20 mg is indicated for the treatment of erectile dysfunction in adult men. This occurs when a man cannot obtain or maintain a firm erection, suitable for satisfactory sexual activity. Tadalafil has shown significant improvement in the ability to achieve a lasting erection of the penis suitable for sexual activity.

Tadalafil Tarbis contains the active ingredient tadalafil, which belongs to a group of medications called phosphodiesterase type 5 inhibitors. After sexual stimulation, tadalafil acts by helping to relax the blood vessels in the penis, allowing blood flow to the penis. The result is an improvement in erectile function. Tadalafil Tarbis will not help if you do not have erectile dysfunction.

It is essential to warn you that Tadalafil Tarbis is not effective if there is no sexual stimulation. Therefore, you and your partner should stimulate each other in the same way as you would if you were not taking a medication for erectile dysfunction.

2. What you need to know before taking Tadalafil Tarbis

Do not take Tadalafil Tarbis if:

• you are allergic to the active ingredient or any of the other components of this medication (listed in section 6).

• you are taking any type of organic nitrates or nitric oxide donors, such as amyl nitrite. This is a group of medications ("nitrates") used to treat angina pectoris ("chest pain"). It has been seen that tadalafil increases the effects of these medications. If you are taking any type of nitrate or are unsure, tell your doctor.

• you have a severe heart disease or have recently suffered a heart attack, in the last 90 days.

• you have recently suffered a stroke, in the last 6 months.

• you have low blood pressure or uncontrolled high blood pressure.

• you have ever experienced loss of vision due to non-arteritic anterior ischemic optic neuropathy (NAION), a disease described as "eye infarction".

• you are taking riociguat. This medication is used to treat pulmonary arterial hypertension (i.e., high blood pressure in the lungs) and chronic thromboembolic pulmonary hypertension (i.e., high blood pressure in the lungs caused by blood clots). Phosphodiesterase type 5 inhibitors, such as tadalafil, have shown that they increase the hypotensive effect of this medication. If you are taking riociguat or are unsure, consult your doctor.

Warnings and precautions

Consult your doctor before starting to take Tadalafil Tarbis.

Be aware that sexual activity carries a possible risk in patients with heart problems, due to the additional effort it requires for the heart. If you have a heart problem, consult your doctor.

Before taking the tablets, inform your doctor if you have:

• sickle cell anemia (an abnormality of red blood cells).
• multiple myeloma (bone marrow cancer).
• leukemia (blood cell cancer).
• any penile deformation.
• a severe liver problem.
• a severe kidney problem.

It is not known if Tadalafil Tarbis is effective in patients who have undergone:

• surgery in the pelvic area.
• a surgical intervention in which the prostate was totally or partially removed and the prostate nerves were cut (radical prostatectomy without preservation of neurovascular bundles).

If you experience a sudden decrease or loss of vision, or your vision is distorted or diminished while taking Tadalafil Tarbis, stop taking this medication and contact your doctor immediately.

A decrease or sudden loss of hearing has been observed in some patients taking tadalafil. Although it is not known if the event is directly related to tadalafil, if you experience a decrease or sudden loss of hearing, stop taking Tadalafil Tarbis and contact your doctor immediately.

Tadalafil Tarbis is not intended for use in women.

Children and adolescents

Tadalafil Tarbis should not be used in children or adolescents under 18 years of age.

Use of Tadalafil Tarbis with other medications

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

Do not take Tadalafil Tarbis if you are already using nitrates.

Some medications may be affected by Tadalafil Tarbis or may affect the proper functioning of Tadalafil Tarbis. Tell your doctor or pharmacist if you are using:

• an alpha-blocker (used to treat high blood pressure or urinary symptoms associated with benign prostatic hyperplasia).
• other medications for high blood pressure.
• riociguat.
• a 5-alpha reductase inhibitor (used to treat benign prostatic hyperplasia).
• medications such as ketoconazole tablets (for the treatment of fungal infections) and protease inhibitors for the treatment of AIDS or HIV infection.
• phenobarbital, phenytoin, and carbamazepine (anticonvulsant medications).
• rifampicin, erythromycin, clarithromycin, or itraconazole.
• other treatments for erectile dysfunction.

Taking Tadalafil Tarbis with drinks and alcohol

Information about the effect of alcohol can be found in section 3. Grapefruit juice may affect the proper functioning of Tadalafil Tarbis and should be taken with caution. Consult your doctor for more information.

Fertility

In dogs treated with tadalafil, a decrease in sperm production by the testicles was observed. A reduction in sperm has been observed in some men. It is unlikely that these effects will produce a lack of fertility.

Driving and using machines

Some men who took tadalafil during clinical trials experienced dizziness. Carefully check how you react when taking the tablets before driving or using machines.

Tadalafil Tarbis contains lactose:

If you have an intolerance to certain sugars, consult your doctor before taking this medication.

3. How to take Tadalafil Tarbis

Follow the administration instructions for this medication exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.

The Tadalafil Tarbis tablets are for oral administration only in men. Swallow the tablet whole with a little water. The tablets can be taken with or without food.

The recommended initial doseis one 10 mg tablet before sexual activity. However, you have been given a dose of one 20 mg tablet because your doctor has decided that the recommended dose of 10 mg is too weak.

When taking Tadalafil Tarbis, you can initiate sexual activity at least 30 minutes after taking it.

Tadalafil Tarbis may still be effective up to 36 hours after taking the tablet.

Do not take Tadalafil Tarbis more than once a day. Tadalafil Tarbis 10 and 20 mg will be used before expected sexual activity and are not recommended for continuous daily use.

It is essential to warn you that Tadalafil Tarbis is not effective if there is no sexual stimulation. Therefore, you and your partner should stimulate each other in the same way as you would if you were not taking a medication for erectile dysfunction.

Consuming alcohol may affect your ability to have an erection and may temporarily lower your blood pressure. If you have taken or are planning to take Tadalafil Tarbis, avoid excessive alcohol consumption (blood alcohol level of 0.08% or higher), as it may increase the risk of dizziness when standing up.

The score line should not be used to split the tablet.

If you take more Tadalafil Tarbis than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested. You may experience side effects described in section 4.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone experiences them. These effects are generally mild to moderate.

If you experience any of the following side effects, stop using the medication and seek medical help immediately:

• allergic reactions, including rash (uncommon).
• chest pain - do not use nitrates, but seek medical help immediately (uncommon).
• priapism, a prolonged and possibly painful erection after taking this medication (rare). If you experience this type of erection, which can last continuously for more than 4 hours, you should contact a doctor immediately.
• sudden loss of vision (rare), distorted, diminished, blurred, or sudden decrease in vision (frequency unknown).

Other side effects that have been reported:

Common(may affect up to 1 in 10 people)

• headache, back pain, muscle pain, pain in the arms and legs, facial flushing, nasal congestion, and indigestion.

Uncommon(may affect up to 1 in 100 people)

• dizziness, stomach pain, nausea, vomiting, reflux, blurred vision, eye pain, difficulty breathing, blood in the urine, prolonged erection, palpitations, rapid heartbeat, high blood pressure, low blood pressure, nosebleeds, ringing in the ears, swelling of the hands, feet, or ankles, and feeling tired.

Rare(may affect up to 1 in 1,000 people)

• fainting, seizures, and transient loss of memory, swelling of the eyelids, red eyes, sudden decrease or loss of hearing, hives (red itchy patches on the skin surface), bleeding from the penis, blood in the semen, and increased sweating.

Myocardial infarction and stroke have also been reported rarely in men taking tadalafil. Most of these men had pre-existing heart problems before taking this medication.

Rarely, cases of decreased or lost vision, partial, transient, or permanent in one or both eyes have been reported.

Some additional rare side effectshave been reported in men taking tadalafil that were not notified during clinical trials. These include:

• migraine, facial swelling, severe allergic reaction that causes facial or throat swelling, severe skin rash, certain disorders that affect blood flow to the eyes, irregular heartbeat, angina pectoris, and sudden cardiac death.
• distorted, diminished, blurred, or sudden decrease in vision (frequency unknown).

In men over 75 years of age treated with tadalafil, the most frequently reported side effect was dizziness. In men over 65 years of age treated with tadalafil, the most frequently reported side effect was diarrhea.

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Tadalafil Tarbis

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date shown on the box and blister after EXP. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need in the SIGRE Collection Point. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Tadalafil Tarbis

• The active ingredient is tadalafil. Each tablet contains 20 mg of tadalafil.
• The other components are:

Tablet core: lactose monohydrate (see the end of section 2), microcrystalline cellulose, povidone, poloxamer, sodium lauryl sulfate, sodium croscarmellose, anhydrous colloidal silica,

film coating: polyvinyl alcohol, macrogol, talc, and titanium dioxide (E171).

Appearance of the product and package contents

Tadalafil Tarbis 20 mg are film-coated tablets, white or almost white, round, biconvex, approximately 5 mm in diameter.

Tadalafil Tarbis 20 mg film-coated tablets are available in aluminum/PVC/PVDC blisters in packs of 28 film-coated tablets.

Marketing authorization holder and manufacturer

Marketing authorization holder

Tarbis Farma, S.L.

Gran Vía Carlos III, 94

08028 Barcelona (Spain)

Manufacturers

Pharmacare Premium Ltd.

HHF003 Hal Far Industrial State,

Hal Far Birzebbugia,

BBG 3000

Malta

Pharmaceutical Works POLPHARMA SA

19, Pelplinska Street

83-200 Starogard Gdanski

Poland

Pharmaceutical Works POLPHARMA, S.A

1 Szypowskiego Street

39-460 Nowa Deba

Poland

This medication is authorized in the Member States of the European Economic Area under the following names:

UK Tadalafil Farmaprojects 20 mg film-coated tablets

DK Tadalafil Farmaprojects

IT Tadalafil Pensa

EL Tadalafil Ariti 20 mg δισκία επικαλυμμ?να με λεπτ? υμ?νιο

Date of the last revision of this leaflet:October 2023.

Other sources of information

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)